These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12161495)

  • 1. Size and oxidative susceptibility of low-density lipoprotein particles in breast cancer patients with tamoxifen-induced fatty liver.
    Wakatsuki A; Ogawa Y; Saibara T; Okatani Y; Fukaya T
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3676-81. PubMed ID: 12161495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Circulation; 2003 Aug; 108(7):808-13. PubMed ID: 12900341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation.
    Siirtola A; Antikainen M; Ala-Houhala M; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
    J Heart Lung Transplant; 2004 Apr; 23(4):418-26. PubMed ID: 15063401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small low-density lipoprotein particles and endothelium-dependent vasodilation in postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Atherosclerosis; 2004 Dec; 177(2):329-36. PubMed ID: 15530907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women.
    Wakatsuki A; Ikenoue N; Okatani Y; Fukaya T
    J Am Coll Cardiol; 2001 Feb; 37(2):425-30. PubMed ID: 11216957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.
    Akhondi-Meybodi M; Mortazavy-Zadah MR; Hashemian Z; Moaiedi M
    Arab J Gastroenterol; 2011 Mar; 12(1):34-6. PubMed ID: 21429453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-induced fatty liver in patients with breast cancer.
    Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
    Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.
    Suzukawa M; Abbey M; Howe PR; Nestel PJ
    J Lipid Res; 1995 Mar; 36(3):473-84. PubMed ID: 7775859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
    Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
    Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin inhibits oxidative modification of low-density lipoprotein particles in normolipidemic post-menopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Izumiya C; Kaneda C
    J Pineal Res; 2000 Apr; 28(3):136-42. PubMed ID: 10739299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Obstet Gynecol; 1997 Jul; 90(1):22-5. PubMed ID: 9207806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.
    Murata Y; Ogawa Y; Saibara T; Nishioka A; Fujiwara Y; Fukumoto M; Inomata T; Enzan H; Onishi S; Yoshida S
    Oncol Rep; 2000; 7(6):1299-304. PubMed ID: 11032933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a dietary oxidized fat on cholesterol in plasma and lipoproteins and the susceptibility of low-density lipoproteins to lipid peroxidation in guinea pigs fed diets with different concentrations of vitamins E and C.
    Eder K; Keller U; Brandsch C
    Int J Vitam Nutr Res; 2004 Jan; 74(1):11-20. PubMed ID: 15060896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of genistein supplementation on tissue genistein and lipid peroxidation of serum, liver and low-density lipoprotein in hamsters.
    Fang YC; Chen BH; Huang RF; Lu YF
    J Nutr Biochem; 2004 Mar; 15(3):142-8. PubMed ID: 15023395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen therapy and hepatic steatosis.
    Coskun U; Törüner FB; Günel N
    Neoplasma; 2002; 49(1):61-4. PubMed ID: 12044063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.